Price
No data yet.
Social Signal Score
Analyst Ratings
6 analystsRevenue
$33.73M+281.95%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Stephen A. Snyder
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 3,650
- Beta
- 2.01
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 1.48
Financials
Revenue
$33.73M+281.9%Net Income
$4.73MEBITDA
$9.82MFree Cash Flow
$5.32MEPS (diluted)
$0.10Shares Outstanding (diluted)
42.53M+323.7%Operating Expenses
$7.31MCash & Debt
$4.64MReturn of Capital
$538.0KRevenue by Segment (annual)
$4.28MDividend per Share
$0.23Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $120.50M | $10.80M | $0.09 |
| 2024 | $110.84M | $7.85M | $-0.28 |
| 2023 | $117.06M | $-48.67M | $-4.11 |
| 2022 | $138.83M | $5.43M | $-0.67 |
| 2021 | $139.60M | $2.84M | $-0.77 |
| 2020 | $105.12M | $-8.81M | $-1.79 |
| 2019 | $64.44M | $-871.8K | $-0.07 |
| 2018 | $50.55M | $-2.14M | $-0.18 |
| 2017 | $31.81M | $-5.57M | $-0.51 |
| 2016 | $24.49M | $-8.80M | $-0.88 |
| 2015 | $23.08M | $-4.69M | $-0.48 |
| 2014 | $18.30M | $-4.51M | $-0.64 |
| 2013 | $10.47M | $-178.0K | $-0.02 |
| 2012 | $10.02M | $117.0K | $0.01 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CCLDP's reported EPS growth of 18.0% a year over 13 years.
- EPS in 5 years
- $0.58
- Implied price
- $18.63
- Return from $19.43
- -0.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $9.26 — -52.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 22 | 27 | 32 | 37 | 42 |
|---|---|---|---|---|---|
| 8.0% | -15.8% | -12.3% | -9.2% | -6.6% | -4.2% |
| 13.0% | -11.9% | -8.2% | -5.0% | -2.2% | 0.3% |
| 18.0% | -8.0% | -4.1% | -0.8% | 2.1% | 4.7% |
| 23.0% | -4.1% | -0.1% | 3.4% | 6.4% | 9.1% |
| 28.0% | -0.2% | 4.0% | 7.6% | 10.7% | 13.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
30+0.00%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·4d ago·Negative
CareCloud Accelerates AI-Powered Growth with Over 40% Reduction in Claim Denials and Multiple New RCM Wins New RCM relationships demonstrate CareCloud's strategy to convert acquisitions, AI innovation and existing customer relationships into recurring revenue opportunities.
View source ↗ - Newsglobenewswire.com·11d ago·Negative
CareCloud Accelerates Wound Care Expansion with New Clients, EHR Integration and Multimillion-Dollar Payer Client Audit Wins New fourth-quarter clients, strategic partnerships and additional payer audit successes strengthen CareCloud's position in the multibillion-dollar wound care market SOMERSET, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management (“RCM”) solutions, toda
View source ↗ - Newsseekingalpha.com·17d ago·Positive
CareCloud, Inc. (CCLD) Q3 2026 Earnings Call Transcript CareCloud, Inc. (CCLD) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·17d ago·Neutral
What CareCloud (CCLD) Said on Its Q3 Earnings Call CareCloud NASDAQ: CCLD reported record third-quarter profit and adjusted EBITDA as revenue growth, automation and a shift toward higher-margin services helped improve profitability. The healthcare technology company also reaffirmed its full-year guidance.
View source ↗ - Newszacks.com·17d ago·Positive
CareCloud, Inc. (CCLD) Tops Q3 Earnings and Revenue Estimates CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.1 per share a year ago.
View source ↗ - Newsglobenewswire.com·54d ago·Negative
CareCloud Promotes Bonnie Boyer to Chief Financial Officer to Lead the Next Growth Phase Experienced finance executive and CPA promoted as CareCloud scales its profitable, AI-powered healthcare technology platform; Norman Roth transitions from Interim CFO to Advisor to the CEO SOMERSET, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that it
View source ↗ - Newstechcrunch.com·95d ago·Neutral
CareCloud confirms 3.7M patients had their medical records stolen in data breach Hackers have stolen the personal information and medical records of more than 3.75 million people in a data breach at health data giant CareCloud, the company has confirmed with federal regulators. The disclosure marks the first confirmation of the scale of the data breach, which is now confirmed to be the fifth-largest theft of health data in 2026 so far.
View source ↗
Insider trading
Open-market buys and sells by CCLDP officers and directors.
- Bought
- —
- Sold
- $354k
0 trades
4 trades
- Daly John Nsold
- Haq Mahmud Ulsold
- Daly John Nsold
- Daly John Nsold
96 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in CCLDP.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
